Pandey A, Li Z, Gautam M, Ghosh A, Man S
Immunol Rev. 2024; 329(1):e13406.
PMID: 39351983
PMC: 11742652.
DOI: 10.1111/imr.13406.
Mo J, Segovia K, Chrzastek K, Briggs K, Kapczynski D
Front Immunol. 2024; 15:1374838.
PMID: 39281683
PMC: 11401072.
DOI: 10.3389/fimmu.2024.1374838.
Bergmann S, Brunotte L, Schughart K
BMC Genom Data. 2024; 25(1):19.
PMID: 38360537
PMC: 10870463.
DOI: 10.1186/s12863-024-01203-3.
Hoyer A, Chakraborty S, Lilienthal I, Konradsen J, Katayama S, Soderhall C
Immun Inflamm Dis. 2024; 12(1):e1162.
PMID: 38270326
PMC: 10797655.
DOI: 10.1002/iid3.1162.
Heger L, Hatscher L, Liang C, Lehmann C, Amon L, Luhr J
Proc Natl Acad Sci U S A. 2023; 120(33):e2300343120.
PMID: 37566635
PMC: 10438835.
DOI: 10.1073/pnas.2300343120.
Anti-influenza A virus restriction factors that shape the human species barrier and virus evolution.
Petric P, Schwemmle M, Graf L
PLoS Pathog. 2023; 19(7):e1011450.
PMID: 37410755
PMC: 10325056.
DOI: 10.1371/journal.ppat.1011450.
HPAI-resistant Ri chickens exhibit elevated antiviral immune-related gene expression.
Vu T, Heo J, Hong Y, Kang S, Tran H, Dang H
J Vet Sci. 2023; 24(1):e13.
PMID: 36726278
PMC: 9899939.
DOI: 10.4142/jvs.22229.
Increased Polymerase Activity of Zoonotic H7N9 Allows Partial Escape from MxA.
Petric P, King J, Graf L, Pohlmann A, Beer M, Schwemmle M
Viruses. 2022; 14(11).
PMID: 36366429
PMC: 9695009.
DOI: 10.3390/v14112331.
Comparison of oseltamivir and α-galactosylceramide for reducing disease and transmission in pigs infected with 2009 H1N1 pandemic influenza virus.
Madrid D, Gu W, Artiaga B, Yang G, Loeb J, Hawkins I
Front Vet Sci. 2022; 9:999507.
PMID: 36337191
PMC: 9635317.
DOI: 10.3389/fvets.2022.999507.
The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling.
Yang H, Dong Y, Bian Y, Xu N, Wu Y, Yang F
Nat Commun. 2022; 13(1):6288.
PMID: 36271046
PMC: 9586965.
DOI: 10.1038/s41467-022-33909-2.
Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution.
Liang W, Tan T, Wang Y, Lv H, Sun Y, Bruzzone R
PLoS Pathog. 2022; 18(9):e1010875.
PMID: 36155668
PMC: 9536752.
DOI: 10.1371/journal.ppat.1010875.
Factors Limiting the Translatability of Rodent Model-Based Intranasal Vaccine Research to Humans.
Cai L, Xu H, Cui Z
AAPS PharmSciTech. 2022; 23(6):191.
PMID: 35819736
PMC: 9274968.
DOI: 10.1208/s12249-022-02330-9.
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera.
Rathnasinghe R, Jangra S, Ye C, Cupic A, Singh G, Martinez-Romero C
Nat Commun. 2022; 13(1):3921.
PMID: 35798721
PMC: 9261898.
DOI: 10.1038/s41467-022-30763-0.
A roadmap for translational cancer glycoimmunology at single cell resolution.
Peixoto A, Miranda A, Santos L, Ferreira J
J Exp Clin Cancer Res. 2022; 41(1):143.
PMID: 35428302
PMC: 9013178.
DOI: 10.1186/s13046-022-02335-z.
Pleiotropic Effects of Influenza H1, H3, and B Baloxavir-Resistant Substitutions on Replication, Sensitivity to Baloxavir, and Interferon Expression.
Hickerson B, Adams S, Barman S, Miller L, Lugovtsev V, Webby R
Antimicrob Agents Chemother. 2022; 66(4):e0000922.
PMID: 35262375
PMC: 9017380.
DOI: 10.1128/aac.00009-22.
Comparative Study of Ten Thogotovirus Isolates and Their Distinct Characteristics.
Fuchs J, Lamkiewicz K, Kolesnikova L, Holzer M, Marz M, Kochs G
J Virol. 2022; 96(5):e0155621.
PMID: 35019718
PMC: 8906411.
DOI: 10.1128/JVI.01556-21.
Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1.
Rathnasinghe R, Salvatore M, Zheng H, Jangra S, Kehrer T, Mena I
Sci Rep. 2021; 11(1):22164.
PMID: 34773048
PMC: 8589955.
DOI: 10.1038/s41598-021-01780-8.
Evidence that two instead of one defective interfering RNA in influenza A virus-derived defective interfering particles (DIPs) does not enhance antiviral activity.
Bdeir N, Arora P, Gartner S, Pohlmann S, Winkler M
Sci Rep. 2021; 11(1):20477.
PMID: 34650149
PMC: 8516915.
DOI: 10.1038/s41598-021-99691-1.
Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.
Van den Hoecke S, Ballegeer M, Vrancken B, Deng L, Job E, Roose K
mBio. 2021; 12(4):e0074521.
PMID: 34253060
PMC: 8406285.
DOI: 10.1128/mBio.00745-21.
Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems.
Murray B, Flores C, Williams C, Flusberg D, Marr E, Kwiatkowska K
Front Cell Infect Microbiol. 2021; 11:691210.
PMID: 34123879
PMC: 8188986.
DOI: 10.3389/fcimb.2021.691210.